Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | CA1 | P00915 | 6/20 | 0.58 |
| ▸ | CA2 | P00918 | 6/20 | 0.58 |
| ▸ | NPC1 | O15118 | 1/20 | 0.58 |
| ▸ | RAB9A | P51151 | 1/20 | 0.58 |
| ▸ | GRK6 | P43250 | 2/20 | 0.43 |
| ▸ | SLC5A2 | P31639 | 1/20 | 0.43 |
| ▸ | ADK | P55263 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7152297 | 0.83 | NPC1 (0.74) | TSHRCA1CA2NPC1RAB9A | |
| SCHEMBL7151149 | 0.83 | NPC1 (0.74) | TSHRCA1CA2NPC1RAB9A | |
| SCHEMBL6045363 | 0.83 | NPC1 (0.74) | TSHRCA1CA2NPC1RAB9A | |
| SCHEMBL9953680 | 0.83 | NPC1 (0.74) | TSHRCA1CA2NPC1RAB9A | |
| SCHEMBL2573474 | 0.82 | NPC1 (0.76) | TSHRCA1CA2NPC1RAB9A | |
| SCHEMBL2573470 | 0.82 | NPC1 (0.76) | TSHRCA1CA2NPC1RAB9A | |
| SCHEMBL7152391 | 0.82 | NPC1 (0.76) | TSHRCA1CA2NPC1RAB9A | |
| SCHEMBL14478652 | 0.82 | NPC1 (0.76) | TSHRCA1CA2NPC1RAB9A | |
| SCHEMBL14353200 | 0.82 | NPC1 (0.76) | TSHRCA1CA2NPC1RAB9A | |
| SCHEMBL7150020 | 0.82 | NPC1 (0.76) | TSHRCA1CA2NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6201116-B1 | FLUORESCENT COMPOUND WITH MIMIMAL PHOTOBLEACHING, REDUCED TOXICITY, RAPID LOADING INTO CYTOPLASM, UNIFORM DISTRIBUTION, CHEMICAL STABILITY; DRUG SCREENING OF MODULATORS OF TRANSPORT PROTEINS (CYSTIC FIBROSIS); MONITORING GENE THERAPY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2001-03-13 | — | — | US | disclosed |